Skip to main content

Month: April 2025

Kestra Medical Technologies Reports Third Quarter Fiscal 2025 Financial Results

KIRKLAND, Wash., April 14, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, today reported financial results for the third quarter fiscal 2025, which ended January 31, 2025. Recent HighlightsQ3 FY25 revenue and gross margin were in line with the preliminary estimated financial results previously disclosed in the company’s IPO prospectus.Generated revenue of $15.1 million in Q3 FY25, an increase of 82% compared to the prior year period. Achieved gross margin of 43.4% in Q3 FY25 compared to 10.6% in the prior year period.Completed initial public offering in March 2025, raising approximately $205.2 million of net proceeds. Signed in-network contracts with additional insurers, with covered lives for the ASSURE® system now totaling more...

Continue reading

GAUMONT: Statement of availability of 2024 Universal registration document

Statement of availability of Universal registration document Neuilly-sur-Seine, April 14, 2025 Filing of the 2024 Universal registration document Gaumont announces that on April 14, 2025, it filed its 2024 Universal registration document to the Autorité des Marchés Financiers (the French financial markets authority). The Universal registration document is available free of charge to the public at Gaumont’s registered office, 30 avenue Charles de Gaulle, 92200 Neuilly-sur-Seine, France, upon request and can also be consulted on the company’s website (https://www.gaumont.com/en/finance/results-publications) and the Autorité des Marchés Financiers website (www.amf-france.org). ** *  AttachmentStatement of availability of 2024 Universal registration document

Continue reading

Sezzle to Announce First Quarter 2025 Results and Participate in Upcoming Investor Conferences

Minneapolis, MN, April 14, 2025 (GLOBE NEWSWIRE) — Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, will release its first quarter 2025 results after the market close on May 7, 2025. The Company will host a conference call and webcast at 5:00pm ET that same day. A replay will be available on the investor relations website following the call. Conference Call RegistrationParticipants can register for the conference call or webcast by navigating to: https://dpregister.com/sreg/10198853/feef6e099b Upon registration, attendees will receive dial-in credentials and a link to the live webcast. Earnings Presentation and Q&ASezzle’s first quarter 2025 earnings presentation will be available shortly after market close on May 7th via the Company’s Investor Relations website. Investors...

Continue reading

DIAGNOS Provides Additional Information on Amendment to Convertible Debentures

BROSSARD, Quebec, April 14, 2025 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of certain ophthalmic health issues using advanced technology based on Artificial Intelligence (AI), wishes to provide additional information to the February 28, 2025 announcement on amendment to convertible debentures. One insider of the Corporation, Mr. André Larente, is the beneficial owner of 2 convertible debentures being amended for a nominal aggregate value of $20,000. Assuming the conversion of the convertible debentures owned by him and exercise of all of his outstanding securities, Mr. Larente would own 2,188,115 Common Shares of the Corporation representing 2.15% of the total issued Common Shares, on a partially diluted basis. Mr. Larente is considered...

Continue reading

Magnera to Report 2025 Second Quarter Results on May 7th

CHARLOTTE, N.C., April 14, 2025 (GLOBE NEWSWIRE) — Magnera (NYSE: MAGN) expects to release its 2025 second quarter results prior to trading on the New York Stock Exchange on Wednesday, May 7, 2025. The earnings release, along with an investor presentation, will be available shortly thereafter on Magnera’s website at Investor Relations – Magnera. In conjunction with its release, Magnera’s Executive team will hold a conference call to discuss the 2025 second quarter financial results at 10:00am (ET) on Wednesday, May 7, 2025. What: 2025 Q2 Magnera Financial Results, Q&A, and Webcast When: Wednesday, May 7, 2025Time: 10:00 a.m. ETTelco: Pre-register (click here to receive dial-in and unique pin for Q&A)Webcast: Listen in option (live and replay) Approximately two hours after the Q&A session, an archived version...

Continue reading

Giga Metals Completes Additional Tranche of Private Placement and Provides Additional Information on First Tranche

NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 14, 2025 (GLOBE NEWSWIRE) — Mark Jarvis, CEO of Giga Metals Corp. (TSX.V – GIGA) (“Giga” or the “Company”) announced today that Giga has completed an additional and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Private Placement”). The Private Placement consists of units (“Units”) issued at a price of $0.10 per Unit. Each Unit consists of one common share and one common share purchase warrant (a “Warrant”). Each Warrant entitles the holder to acquire one additional common share at an exercise price of $0.15 for three years following the date of issuance. Pursuant to the Second Tranche of Private Placement, which completed today, Giga issued 250,000 Units for gross...

Continue reading

VeeMost Technologies Inc Announces Corporate Name, Ticker Symbol, and CUSIP change

Red Bank, NJ, April 14, 2025 (GLOBE NEWSWIRE) — VeeMost Technologies Inc. (OTC: VMST), a leading provider of cutting-edge IT solutions, is pleased to announce that the Financial Industry Regulatory Authority (FINRA) has approved the Company’s official name change from Global Developments, Inc. to VeeMost Technologies Inc., along with a corresponding change in its ticker symbol from GDVM to VMST. These changes were published on the OTC Markets Daily List on April 14, 2025, and will take effect at the open of business on April 15, 2025. In addition to the name and ticker change, the Company has also received approval for a new CUSIP number: 922462106, which will be reflected across all trading and depository systems starting April 15, 2025. This rebranding aligns with the Company’s transformation and renewed strategic focus on delivering...

Continue reading

Can-Fite Announces $3.0 Million Registered Direct Offering of American Depositary Shares

RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory diseases (“Can-Fite” or the “Company”), today announced that it has entered into definitive agreements for the purchase and sale of 2,500,000 of the Company’s American Depositary Shares (“ADSs”), at a purchase price of $1.20 per ADS, in a registered direct offering. The offering is expected to close on or about April 15, 2025, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds from the, before deducting the placement agent’s fees and other offering expenses payable by the Company, are expected...

Continue reading

Music Licensing, Inc. (OTC: SONG) and Pro Music Rights, Inc. Call for Major Reform in U.S. Music Licensing Industry in Formal Response to Copyright Office Inquiry

Naples, FL, April 14, 2025 (GLOBE NEWSWIRE) — Music Licensing, Inc. (OTC: SONG) and its wholly owned subsidiary Pro Music Rights, Inc. (PMR) have submitted a detailed and forceful response to the U.S. Copyright Office’s Notice of Inquiry (Docket No. 2025–1), shining a spotlight on longstanding anti-competitive behavior by legacy Performing Rights Organizations (PROs) such as BMI and ASCAP, while offering a bold and transparent alternative through PMR’s equitable licensing model. Challenging the Status Quo: PMR’s submission criticizes legacy PROs for opaque revenue distributions, excessive payouts to private equity owners, and international licensing strong-arming via the global collective CISAC network. According to the filing, BMI—once a nonprofit—has covertly transformed into a for-profit entity, now diverting up to 20% of its...

Continue reading

CSX Honors 62 Customers with Annual Chemical Safety Excellence Award

JACKSONVILLE, Fla., April 14, 2025 (GLOBE NEWSWIRE) — CSX Corporation (NASDAQ: CSX) has recognized 62 customers with its 31st Annual Chemical Safety Excellence Award for their dedication to safely transporting hazardous materials across the company’s rail network in 2024. For more than three decades, the award has honored chemical customers who prioritize safety in every shipment, reflecting their commitment to protecting CSX employees, the surrounding communities, and the environment. It also underscores rail as the safest mode of land transportation for hazardous chemicals. To qualify, customers must ship at least 600 carloads of hazardous materials during the year with zero non-accidental releases of regulated substances. The 2024 award recipients collectively shipped 164,438 carloads safely, demonstrating the highest level...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.